A man has revealed he dropped 12 stone in just ... didn't resort to a weight loss jab such as Ozempic or Wegovy, which millions have used to slim down. The receptionist, who weighed 25st 1lb ...
Our grey matter has always been a mystery, even to neurologists, but Professor Masud Husain says life-changing advances may ...
There are early signs, too, that weight-loss jabs such as Wegovy may also improve cognitive ... a risk for young-onset dementia if you’re a man. It isn’t clear if treatment can reduce your ...
Kathryn Thomas has just delivered her new two-part documentary The Skinny Jab Revolution, to RTÉ, and hasraced into us here ...
The Danish maker of Ozempic and Wegovy reported a 25 percent increase in sales to $40.6 billion, but said it expected slower growth this year. By Eshe Nelson Reporting from London Novo Nordisk ...
Ozempic and Wegovy maker Novo Nordisk quieted Wall Street’s concerns with its fourth-quarter results and 2025 outlook.
A charity boss who once tipped the scales at more than 28st says weight-loss injections have changed the way he thinks about ...
The company's blockbuster semaglutide drugs, Wegovy for weight loss and Ozempic for diabetes, were key to its earnings beat. Combined, they brought in $24.9 billion for the year. That's compared ...
In fact, Novo Nordisk recently reported positive results for one of its anti-obesity candidates that puts its current best-selling drug in this area, Wegovy, to shame. Let's look deeper into these ...
In addition to Wegovy, its sister drug Ozempic, indicated for diabetes, and NVO’s oral GLP-1 agonist Rybelsus have also been selected for the negotiation round. Other drugs included in the list ...
The company is spending billions to ramp up its Wegovy output as demand soars. "Emissions come with growth," said Katrine DiBona, corporate vice president of global public affairs and ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results